The Effect of Forgiveness-based Motivational Interviewing

NCT07365943 | Completed

• 1 other identifier: MERVE-RCT-2025-COPD
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

This study aimed to examine the effect of forgiveness-based motivational interviewing on death anxiety, life satisfaction, and forgiveness disposition in patients with COPD. A randomized controlled experimental design with pretest, posttest, and one-month follow-up measurements was employed. The study sample consisted of 30 patients (experimental group: 15; control group: 15). The experimental group received forgiveness-based motivational interviewing, whereas no intervention was provided to the control group. Data were collected using a personal information form, the Death Anxiety Scale, the Life Satisfaction Scale, and the Forgiveness Scale. The findings revealed that, in the posttest and follow-up measurements, the experimental group had significantly lower mean scores on the Death Anxiety Scale compared to the control group (p\<0.05). Furthermore, the experimental group demonstrated significantly higher mean scores on the Life Satisfaction Scale and the Forgiveness Scale in the posttest and follow-up measurements than the control group (p\<0.05). This study concluded that forgiveness-based motivational interviewing effectively reduces death anxiety while enhancing life satisfaction and forgiveness disposition in patients with COPD. Therefore, implementing motivational interviewing for patients is recommended.

Conditions

Psychiatric Nursing; Psychoeducation; COPD (Chronic Obstructive Pulmonary Disease); Forgiveness

Keywords

Death anxiety; forgiveness; life satisfaction; COPD; motivational interviewing

Outcome Measures

Primary Outcomes (1)

• Death Anxiety Scale

  The scale is a unidimensional, dichotomous Likert-type instrument consisting of 15 items that assess an individual's anxiety related to their own death and the risk of dying. Each item is answered as "yes" or "no," where a "yes" response for the first nine items and a "no" response for the remaining six items receive one point. The total score ranges from 0 to 15, with higher scores indicating greater death anxiety.

  Baseline (pretest), 3 weeks (posttest) and one month after the posttest

Secondary Outcomes (1)

• Forgiveness scale

  Baseline (pretest), 3 weeks (posttest) and one month after the posttest

Other Outcomes (1)

• Life satisfaction scale

  Baseline (pretest), 3 weeks (posttest) and one month after the posttest

Study Arms (2)

forgiveness-based motivational interviewing

EXPERIMENTAL

Participants will receive an 6-session forgiveness-based motivational interviewing

Other: forgiveness-based motivational interviewing; Other: Control

Control

NO INTERVENTION

Throughout the study, the forgiveness-based motivational interviewing was applied only to the experimental group, and no intervention was performed in the control group

Interventions

forgiveness-based motivational interviewing OTHER

The forgiveness-based motivational interviewing was administered face-to-face, with each session lasting 40-60 minutes, scheduled twice a week over a three-week period (a total of six sessions).

forgiveness-based motivational interviewing

Control OTHER

no intervention was performed in the control group

forgiveness-based motivational interviewing

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• They must be 18 years of age or older,
• Possess sufficient mental capacity and communication skills to follow the study guidelines, be literate,
• Have a diagnosis of COPD,
• Have been hospitalized in the pulmonary diseases unit between June and September 2024.

You may not qualify if:

• Determined having communication barriers due to disease symptoms,
• Experiencing dyspnea at a level that prevents cooperation
• Having a chronic psychiatric disorder that would interfere with participation in the study.

Sponsors & Collaborators

• Ömer USLU: lead

Study Sites (1)

Bergama Necla Mithat Öztüre State Hospital

Izmir, Bergama, 35700, Turkey (Türkiye)

Location

Related Links

• Bergama Necla Mithat Öztüre State Hospital

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Necrophobia; Personal Satisfaction

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Behavior

Study Officials

• Merve Şahin, PhD, RN

  Bergama Necla Mithat Öztüre State Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Dr. Ömer USLU, PhD-Principal Investigator

Model Details: This study used a pretest-posttest-follow-up randomised controlled experimental method. Participants were randomly assigned to either the experimental group (forgiveness based motivational interviewing) or the control group with no intervention.

Study Record Dates

• First Submitted: January 17, 2026
• First Posted: January 26, 2026
• Study Start: June 1, 2024
• Primary Completion: September 27, 2024
• Study Completion: September 30, 2024
• Last Updated: January 26, 2026

Record last verified: 2026-01

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)